Here, we used a common DIO procedure in combination with precise CRISPR-dCas9-TET1 and dCas9-DNMT3a mediated manipulations of the Pomc promoter to determine the contribution of Pomc DNA methylation changes to abnormal weight gain during the development of obesity. Here, DNMT3A is linked to obesity disorder.